Endocrinology research centre statement about COVID-19 vaccination of diabetes mellitus patients

1. Gregory JM, Slaughter JC, Duffus SH, et al. COVID-19 Severity Is Tripled in the Diabetes Community: A Prospective Analysis of the Pandemic’s Impact in Type 1 and Type 2 Diabetes. Diabetes Care. 2021;44(2):526-532. https://doi.org/10.2337/dc20-2260

2. Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430-436. https://doi.org/10.1038/s41586-020-2521-4

3. Shestakova MV, Vikulova OK, Isakov MA, Dedov II. [Diabetes and COVID-19: analysis of the clinical outcomes according to the data of the russian diabetes registry. Problems of Endocrinology. 2020;66(1):35-46. (In Russ.). https://doi.org/10.14341/probl12458

4. Письмо Минздрава России от 28.12.2020 N 1/и/1-9601 «О порядке проведения вакцинации против COVID-19 взрослому населению».

5. Statement on Kidney Patient Prioritization for COVID-19 Vaccines and Therapeutics. National Kidney Foundation. Available from: www.kidney.org

6. COVID-19 vaccination for adult patients with kidney disease: a position statement from the UK renal community. Available from: www.kidneycareuk.org/coronavirus.